Medical Properties Trust, Inc. MPW — also known as MPT — reported first-quarter 2025 normalized funds from operations (NFFO) per share of 14 cents, missing the Zacks Consensus Estimate of 15 cents. This compared unfavorably with 24 cents per share recorded in the prior-year quarter. Results reflect a decrease in rent billed and straight-line rent revenues. Also, an increase in interest expenses in the quarter remains a concern. MPT clocked in revenues of $223.8 million in the first quarter, missing the Zacks Consensus Estimate by 5.1%. The figure declined 17.5% from the year-ago quarter. Per Edward K. Aldag, Jr., chairman, president and CEO, “Our first quarter transactions and results are the culmination of two years of successful efforts to reduce debt, extend maturities, capture unrealized value, and re-tenant hospital real estate at attractive and sustainable rents. MPT is well positioned to grow earnings from our existing in-place real estate portfolio, access capital for accretive growth in a uniquely attractive market and deliver growing dividends and other returns to our shareholders.” Behind the Headlines In the reported quarter, Medical Properties’ rent billed totaled $165.2 million, decreasing 17.1% from the prior-year quarter. Its straight-line rent revenues were $40.1 million, down 10.3% from the year-ago quarter. Income from financing leases of $9.9 million in the first quarter decreased 39.6% from the year-ago quarter. Interest and other income was $8.6 million, down 21.2% from the year-ago period. Medical Properties’ interest expenses were up 6.5% year over year to $115.8 million. MPW's Balance Sheet Position Medical Properties exited the first quarter of 2025 with cash and cash equivalents of $673.5 million, up from $332.3 million as of Dec. 31, 2024. As of March 31, 2025, it had an adjusted net debt to adjusted annualized EBITDA ratio of 9.9. MPW’s Zacks Rank Medical Properties currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. Medical Properties Trust, Inc. Price, Consensus and EPS SurpriseMedical Properties Trust, Inc. Price, Consensus and EPS Surprise Medical Properties Trust, Inc. price-consensus-eps-surprise-chart | Medical Properties Trust, Inc. Quote Performance of Other REITs Digital Realty Trust DLR reported first-quarter 2025 core funds from operations (FFO) per share of $1.77, beating the Zacks Consensus Estimate of $1.73. The FFO also increased 6% year over year. (See the Zacks Earnings Calendar to stay ahead of market-making news.) Results reflected steady leasing momentum with better rental rates amid rising demand. However, higher operating expenses undermined the performance to an extent. DLR raised its 2025 core FFO guidance range. Story Continues Alexandria Real Estate Equities, Inc. ARE reported first-quarter 2025 adjusted funds from operations (AFFO) per share of $2.30, beating the Zacks Consensus Estimate of $2.28. This compares unfavorably to the AFFO of $2.35 reported in the prior year. Results reflected decent leasing activity and rental rate growth. However, lower occupancy and higher interest expenses year over year undermined the results to some extent. ARE has revised its 2025 outlook. Note: Anything related to earnings presented in this write-up represents funds from operations (FFO), a widely used metric to gauge the performance of REITs. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Digital Realty Trust, Inc. (DLR):Free Stock Analysis Report Alexandria Real Estate Equities, Inc. (ARE):Free Stock Analysis Report Medical Properties Trust, Inc. (MPW):Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research View Comments
Medical Properties Q1 NFFO Misses Estimates, Revenues Fall Y/Y
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...